Source-grounded facts extracted from Bio Essence Corp's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Bio Essence Corp entered into Asset Purchase Agreement with Zhituo Software Co., Limited valued at $3,500,000 (effective 2026-04-20).
“On April 20, 2026, Bio Essence Corp., a California corporation (“Company”) entered into a Asset Purchase Agreement (“APA”) with Zhituo Software Co., Limited, a company incorporated under the laws of Hong Kong (“Zhituo”).”
William Sluss was appointed as Director at Bio Essence Corp.
“On June 18, 2024, the Company’s remaining directors unanimously appointed William Sluss to the Board of Directors pursuant to Article II, Section 6 of the Company’s Bylaws.”
Simon Shavanson resigned as Director at Bio Essence Corp.
“On June 12, 2024, Yangyang Huang and Simon Shavanson (collectively the “Resigning Directors”) resigned from the Board of Directors of Bio Essence Corp. (the “Company”).”
Yangyang Huang resigned as Director at Bio Essence Corp.
“On June 12, 2024, Yangyang Huang and Simon Shavanson (collectively the “Resigning Directors”) resigned from the Board of Directors of Bio Essence Corp. (the “Company”).”
Bio Essence Corp entered into Stock Purchase Agreement with Health Up, Inc. valued at Four Hundred Thousand Dollars ($400,000) (effective 2024-03-28).
“On March 28, 2024, Bio Essence Corp., a California corporation (“Company”) entered into a Stock Purchase Agreement (“SPA”) with Health Up, Inc., a California corporation (“HUI”) whereby the Company agreed to sell to HUI its wholly owned subsidiary, Bio Essence Herbal Essentials, Inc. d/b/a Bio Essence Health Science, a California corporation (“BEP”), in exchange for cash consideration in the amount of Four Hundred Thousand Dollars ($400,000).”
Bio Essence Corp entered into Stock Purchase Agreement with Newways, Inc. valued at cash consideration in the amount of Three Hundred Thousand Dollars ($300,000) (effective 2023-12-12).
“On December 12, 2023, Bio Essence Corp., a California corporation (the “Company”) entered into a Stock Purchase Agreement (“SPA”) with Newways, Inc., a California corporation (“Newways”) whereby the Company agreed to sell to Newways its wholly owned subsidiary, Bio Essence Pharmaceutical, Inc. (“BEP”), in exchange for cash consideration in the amount of Three Hundred Thousand Dollars ($300,000).”
Sharon Mair resigned as Director at Bio Essence Corp.
“On December 8, 2023, the Company received notice from Sharon Mair, a member of the Company’s Board of Directors, that she resigned from the Board of Directors effective immediately.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.